Dwight J. Hardy

4.2k total citations · 1 hit paper
89 papers, 3.0k citations indexed

About

Dwight J. Hardy is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Dwight J. Hardy has authored 89 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 35 papers in Epidemiology and 33 papers in Pharmacology. Recurrent topics in Dwight J. Hardy's work include Antibiotic Resistance in Bacteria (28 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Pneumonia and Respiratory Infections (25 papers). Dwight J. Hardy is often cited by papers focused on Antibiotic Resistance in Bacteria (28 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers) and Pneumonia and Respiratory Infections (25 papers). Dwight J. Hardy collaborates with scholars based in United States, United Kingdom and Canada. Dwight J. Hardy's co-authors include Prabhavathi Fernandes, R. N. Swanson, Dena M. Hensey, C W Hanson, Edith McDonald, Jill Beyer, N. L. Shipkowitz, Jacob J. Clement, Ronald N. Jones and Barbara Zimmer and has published in prestigious journals such as Nucleic Acids Research, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Dwight J. Hardy

86 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

2018 519 citations Romney M. Humphries, Jane E. Ambler et al. Journal of Clinical Microbiology profile →

Peers

Dwight J. Hardy

EPIDE

PHARM

Andrea Novelli Italy

A. Bryskier France

Glenn Tillotson United States

Itamar Shalit Israel

Luciano Zubaran Goldani Brazil

Gian Carlo Schito Italy

Gary E. Stein United States

Matthew A. Wikler United States

Joseph M. Blondeau Canada

Robert H.K. Eng United States

Andrea Novelli Italy

Dwight J. Hardy

1.2k ×1.0

EPIDE

950 ×1.2

744 ×1.0

1.3k ×2.0

PHARM

471 ×0.8

Citations per year, relative to Dwight J. Hardy Dwight J. Hardy (= 1×) peers Andrea Novelli

Countries citing papers authored by Dwight J. Hardy

Since Specialization

Citations

This map shows the geographic impact of Dwight J. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwight J. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwight J. Hardy more than expected).

Fields of papers citing papers by Dwight J. Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwight J. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwight J. Hardy. The network helps show where Dwight J. Hardy may publish in the future.

Co-authorship network of co-authors of Dwight J. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Dwight J. Hardy. A scholar is included among the top collaborators of Dwight J. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwight J. Hardy. Dwight J. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koeth, Laura, et al.. (2024). A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Journal of Clinical Microbiology. 63(2). e0092624–e0092624. 1 indexed citations

Connelly, Sara M., et al.. (2023). Species Delineation and Comparative Genomics within theCampylobacter ureolyticusComplex. Journal of Clinical Microbiology. 61(5). e0004623–e0004623. 6 indexed citations

Connelly, Sara M., et al.. (2023). Complete genome sequence of a human bacteremia isolate of Kalamiella piersonii. Microbiology Resource Announcements. 12(9).

Connelly, Sara M., et al.. (2022). Whole-Genome Sequences of Human Monkeypox Virus Strains from Two 2022 Global Outbreak Cases in Western New York State. Microbiology Resource Announcements. 11(12). e0084622–e0084622. 3 indexed citations

Malek, Adel, Samantha Taffner, Lynn Fine, et al.. (2019). Next-Generation-Sequencing-Based Hospital Outbreak Investigation Yields Insight into Klebsiella aerogenes Population Structure and Determinants of Carbapenem Resistance and Pathogenicity. Antimicrobial Agents and Chemotherapy. 63(6). 36 indexed citations

Humphries, Romney M., Jane E. Ambler, Stephanie L. Mitchell, et al.. (2018). CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests. Journal of Clinical Microbiology. 56(4). 519 indexed citations breakdown →

Raghuram, Anupama, Alejandro Restrepo, Saman Safadjou, et al.. (2012). Invasive fungal infections following liver transplantation: Incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). Liver Transplantation. 18(9). 1100–1109. 55 indexed citations

Hardy, Dwight J., et al.. (2012). A Single-Blinded Randomized Clinical Trial Comparing Polymyxin B-Trimethoprim and Moxifloxacin for Treatment of Acute Conjunctivitis in Children. The Journal of Pediatrics. 162(4). 857–861. 15 indexed citations

Knight, Kristin, et al.. (2011). The effect of intrapartum clindamycin on vaginal group B streptococcus colony counts. The Journal of Maternal-Fetal & Neonatal Medicine. 25(6). 747–749. 4 indexed citations

10.

Glantz, J. Christopher, et al.. (2007). The effect of intrapartum penicillin on vaginal group B streptococcus colony counts. American Journal of Obstetrics and Gynecology. 197(6). 583.e1–583.e4. 23 indexed citations

11.

Korones, David N., et al.. (2002). High incidence of penicillin resistance among α-hemolytic streptococci isolated from the blood of children with cancer. The Journal of Pediatrics. 140(1). 20–26. 16 indexed citations

12.

Barry, A L, Peter Fuchs, C Thornsberry, et al.. (1996). Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. European Journal of Clinical Microbiology & Infectious Diseases. 15(8). 676–678. 3 indexed citations

13.

Barry, A L, Michael A. Pfaller, Peter Fuchs, et al.. (1993). Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. European Journal of Clinical Microbiology & Infectious Diseases. 12(5). 352–356. 10 indexed citations

14.

Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1993). Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates ofEnterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases. 12(3). 200–205. 5 indexed citations

15.

Hardy, Dwight J.. (1993). Extent and spectrum of the antimicrobial activity of clarithromycin. The Pediatric Infectious Disease Journal. 12(12 Suppl 3). S99–S105. 19 indexed citations

16.

Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1992). Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 728–732. 6 indexed citations

17.

Lartey, Paul A., Shari L. DeNinno, Ramin Faghih, et al.. (1992). Synthesis and activity of C-21 alkylamino derivatives of (9R)-erythromycylamine.. The Journal of Antibiotics. 45(3). 380–385. 10 indexed citations

18.

Lartey, Paul A., Shari L. DeNinno, Ramin Faghih, et al.. (1991). Synthesis and antibacterial activities of C-21 functionalized derivatives of (9R)-9-amino-9-deoxoerythromycins A and B. Journal of Medicinal Chemistry. 34(12). 3390–3395. 10 indexed citations

19.

Chu, Daniel T. W., Carl W. Nordeen, Dwight J. Hardy, et al.. (1991). Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride. Journal of Medicinal Chemistry. 34(1). 168–174. 39 indexed citations

20.

Barry, A L, J H Jorgensen, & Dwight J. Hardy. (1991). Reproducibility of disc susceptibility tests with Haemophilus influenzae. Journal of Antimicrobial Chemotherapy. 27(3). 295–301. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact